Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer’s disease-related dysregulation

Abstract

The differentially methylated regions may help understand the interaction between methylation alterations and cognitive function. In addition, ADAM10 might be a valuable blood-based biomarker for at least the early detection of AD.